Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wenyu Lin

Showing results (51-60 of 121) with videos related to

Pageof 13
Sort By:
Hepatology (Baltimore, Md.)|February 22, 2005
Hepatitis C virus acts as a tumor accelerator by blocking apoptosis in a mouse model of hepatocarcinogenesisYoshitaka Kamegaya, Yoichi Hiasa, Lawrence Zukerberg, et al.
Journal of Hepatology|March 1, 2011
Naringenin inhibits the assembly and long-term production of infectious hepatitis C virus particles through a PPAR-mediated mechanismJonathan Goldwasser, Pazit Y Cohen, Wenyu Lin, et al.
Infectious Agents and Cancer|January 28, 2025
Risk of residual/recurrent cervical diseases in HPV-positive women post-conization depends on HPV integration statusWenyu Lin, Yuxuan Huang, Yan Zhang, et al.
Respiratory Research|December 16, 2025
Lipopolysaccharide-induced histone lactylation mediates m6A RNA modification causing mitochondrial dysfunction and pulmonary fibroblasts activation to exacerbate sepsis-associated pulmonary fibrosisRi Tang, Shaojie Qin, Qiaoyi Xu, et al.
Vaccines|June 27, 2024
Safety Assessment of Concurrent Vaccination with the HPV Vaccine and the COVID-19 Vaccine in Fujian Province, China: A Retrospective StudyYan Zhang, Yuhang Zhang, Binhua Dong, et al.
Gastroenterology|January 24, 2007
A cell-based, high-throughput screen for small molecule regulators of hepatitis C virus replicationSun Suk Kim, Lee F Peng, Wenyu Lin, et al.
Viruses|April 12, 2020
2', 5'-Oligoadenylate Synthetase 2 (OAS2) Inhibits Zika Virus Replication through Activation of Type Ι IFN Signaling PathwayXinzhong Liao, He Xie, Shilin Li, et al.
Journal of Inflammation Research|May 8, 2023
Platelet-to-Lymphocyte Ratio (PLR) as the Prognostic Factor for Recurrence/Residual Disease in HSIL Patients After LEEPGuanxiang Huang, Hangjing Gao, Yanlin Chen, et al.
Frontiers in Medicine|December 20, 2021
Assessment of Non-invasive Markers for the Prediction of Esophageal Variceal HemorrhageShasha Li, Peng Huang, Andre J Jeyarajan, et al.
Journal of Hepatology|December 15, 2010
IL28B inhibits hepatitis C virus replication through the JAK-STAT pathwayLeiliang Zhang, Nikolaus Jilg, Run-Xuan Shao, et al.
Pageof 13

Showing results (51-60 of 121) with videos related to

Sort By:
Pageof 13
Hepatology (Baltimore, Md.)|February 22, 2005
Hepatitis C virus acts as a tumor accelerator by blocking apoptosis in a mouse model of hepatocarcinogenesisYoshitaka Kamegaya, Yoichi Hiasa, Lawrence Zukerberg, et al.
Journal of Hepatology|March 1, 2011
Naringenin inhibits the assembly and long-term production of infectious hepatitis C virus particles through a PPAR-mediated mechanismJonathan Goldwasser, Pazit Y Cohen, Wenyu Lin, et al.
Infectious Agents and Cancer|January 28, 2025
Risk of residual/recurrent cervical diseases in HPV-positive women post-conization depends on HPV integration statusWenyu Lin, Yuxuan Huang, Yan Zhang, et al.
Respiratory Research|December 16, 2025
Lipopolysaccharide-induced histone lactylation mediates m6A RNA modification causing mitochondrial dysfunction and pulmonary fibroblasts activation to exacerbate sepsis-associated pulmonary fibrosisRi Tang, Shaojie Qin, Qiaoyi Xu, et al.
Vaccines|June 27, 2024
Safety Assessment of Concurrent Vaccination with the HPV Vaccine and the COVID-19 Vaccine in Fujian Province, China: A Retrospective StudyYan Zhang, Yuhang Zhang, Binhua Dong, et al.
Gastroenterology|January 24, 2007
A cell-based, high-throughput screen for small molecule regulators of hepatitis C virus replicationSun Suk Kim, Lee F Peng, Wenyu Lin, et al.
Viruses|April 12, 2020
2', 5'-Oligoadenylate Synthetase 2 (OAS2) Inhibits Zika Virus Replication through Activation of Type Ι IFN Signaling PathwayXinzhong Liao, He Xie, Shilin Li, et al.
Journal of Inflammation Research|May 8, 2023
Platelet-to-Lymphocyte Ratio (PLR) as the Prognostic Factor for Recurrence/Residual Disease in HSIL Patients After LEEPGuanxiang Huang, Hangjing Gao, Yanlin Chen, et al.
Frontiers in Medicine|December 20, 2021
Assessment of Non-invasive Markers for the Prediction of Esophageal Variceal HemorrhageShasha Li, Peng Huang, Andre J Jeyarajan, et al.
Journal of Hepatology|December 15, 2010
IL28B inhibits hepatitis C virus replication through the JAK-STAT pathwayLeiliang Zhang, Nikolaus Jilg, Run-Xuan Shao, et al.
Pageof 13